
|Articles|January 20, 2008
Inhaled ciclesonide given nod by FDA
Alvesco approved for asthma
Advertisement
Prodrug ciclesonide, activated by intracellular esterases following oral inhalation, has been approved by the FDA as an inhalation aerosol for use as a prophylactic therapy in adults and adolescents aged 12 years and older with asthma. The drug is called a new generation of corticosteroid by manufacturer
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
2
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
3
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
4
Wicked Good Cardiometabolic Chat: Once-Weekly Insulin Management
5







































